mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD

Similar documents
sick contact1l

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI



2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,

(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..

ph

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

JHN Journal Club 手稲渓仁会病院

/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg

SBP hospitalist network.key


近畿中国四国農業研究センター研究報告 第7号

デスフルラン

_02三浦.indd

untitled

untitled

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter)

2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 percutaneous coronary intervention PCI

20-121

PowerPoint プレゼンテーション

日本呼吸器学会雑誌第44巻第10号

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

- 9 91, (2006)

ONO L 0.03mg/kg/min 1min 0.01mg/kg/min 10min M 0.03mg/kg/min 1min 0.02mg/kg/min 10min H 0.06mg/kg/min 1min 0.04mg/kg/min 10min 3 1) LSD p=0.000

慈大呼吸器_25-1_02T_CS5.indd

untitled

Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2

Microsoft Word - 平成24年度医学部卒業試験問題-2.docx


untitled

Sample2 g/dl Target1 : 6.01 g/dl TP Target2 : 8.39 g/dl



終末期の呼吸困難症状への対応*松坂最終修正

() 90

QA JOURNAL RADIOMETER June No. C O N T E N T S 2 6 8

[] 1

64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () m/s : : a) b) kg/m kg/m k

日本呼吸器学会雑誌第44巻第1号

WBC 5700 / l Gran 58.5% Lym 29.0% Eosin 0.3% RBC 499x10 6 / l Hb 14.8 g/dl Hct 44.40% PLT 15.3x10 3 / l PT 157% Fbg 616 mg/dl DD 0.99 g/ml GOT GPT LDH

....

ONS60409_gencyo.indd

温泉の化学 1

_06.indd

日本呼吸器学会雑誌第48巻第6号


22 1 (-) AST 82 IU/L ANA 40x (-) ALT 46 IU/L homogeneous+speckled γ-gt 21 IU/L RF (-) 10,280 / μl LD 364 IU/L Anti-RNP Ab (-) 9,230 / μl BUN 11.9 mg/d

1 Blood chemistry Peripheral blood Viral marker TP 5.4 g dl WBC ml Syphilis TPAb Alb 2.7 g dl RBC ml HBsAg T. bil 2.3 mg dl Hb 11 g dl

‰Łflç‘ÇŁ\”ƒ(’FŁª›ð)-A4

C/NC : committed/noncommitted

橡

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

untitled


Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

コロイド化学と界面化学

筑波大学第一学群自然学類 水文学野外実験B実施計画

5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU


untitled

20 57

九州支部卒後研修会症例

/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1


DFC Dialysis Facility Compare g/dl UPR65% UPR BUN BUN/ BUN NEJM, March10,2005 Anemia of C

MNT MNT CVD MNT 1) 2) 3) 4) MNT 1) 1 2 2) MNT MNT MNT MNT % HbA1C 2

1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61

<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63>

m

日本呼吸器学会雑誌第47巻第6号

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

審査報告書(案)

糖尿病薬の保険調剤 留意事項など

高脂血症の検査

4

本文.indd

生化学検査 臨床検査基準値一覧 近畿大学病院 (1) 検査項目 基準値 単位 検査項目 基準値 単位 CRP mg/dl WBC /μl Na mmol/l M RBC K mmol/l F 3.86-

untitled

無印良品 2012 自転車 カタログ

ID POS F

1) Urlne analysls 7)Serologlcal exam. 1 1)ECG W.N.L. sugar 0% CRP (-) urobillnogen N(+) RA (+) 12)Renal function albumin 3(+) ASLO (-) PSP test 15' 40

untitled

untitled

) km 200 m ) ) ) ) ) ) ) kg kg ) 017 x y x 2 y 5x 5 y )

表 1 入院時検査所見 11,500L 471 L 17.0 gdl.3 L ph 7.49 PaCO 37.8 mmhg PaO 67.4 mmhg HCO 3.6 meql B E 1. meql 141 meql K 3.9 meql Cl 108 meql Ca 8.4 mgdl P 4.5

低Na血症の治療

27.\..

2 2

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

CK.... Figure 1. 全症例における血清 CK 値と血糖 値の関係 B. 方法 CK - mu/ml CK CK-MB CK BMI body mass index HbA c GOT GPT LDH-GTP CRP HDL- LDL- BUN egfr Na K Cl Ca P Pos

08症例報告4山内.indd

CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A

診療ガイドラインのカラクリ

本文/一般演題_吉田



小児感染免疫第27巻第4号

Transcription:

31 1 15 20 2016 15 3 65 5 mg 8 mg 10 15 201X 7 1 11 15 Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD AKI HD 2004 48 Acute Kidney Injury AKI 48 Cr 0.3 mg/dl Cr 7 1.5 6 0.5 ml/kg/ AKI 1,2 ATN 409-3898 1110 2016 2 23 2016 3 9 3 CK Mb Mb AKI AKI 13 50 4 5 3

16 65 7 10 5 mg 8 mg 10 15 201X 6 7 1 11 15 166 cm 35.8 kg BMI 13 kg/m 2 89/53 mmhg 66 / 36.5 SpO 2 96 room air 1 LDH BUN 103.8 mg/dl Cr 9.84 mg/dl Ca 6.2 mg/dl Na 129 meq/ L K 1.5 meq/l UA 15.7 mg/ dl P 9.8 mg/dl CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml 2+ 3+ 1.010 ph5.5 Cr 101.4 mg/dl Na 63 meq/l K 10 meq/l Cl 49 meq/l NAG 1

17 1 157.5 U/L β2mg 6,783 ng/ml, Alb 857 mg/l 12 57 bpm V2-V5 ST U 6 mm ph 7.258 pco 2 30.3 mmhg po 2 107 mmhg HCO 3-13.1 mmol/l anion gap 16.8 meq/l lactate 4 mg/dl CT FT31.06 pg/ml, FT4 0.664 ng/ml, TSH 10.490 μiu/ml TPO 1 500 ml/h 6 250 ml/ h 20 meq/h 6 10 meq/ h 3,000 ml 100 ml/90 AKI 2 IHD 10 4 IHD NF1-1.6H 2 FB-110U 150 ml/ 3 2,100 2,500 ml HD egfr 25.2 ml/min/1.73m 2 U-TP 0.78 g/g Cr U-B2MG 23,085 ng/ml fractional excretion of K FEK 16.2 5 egfr 30 ml/min/1.73m 2 U-TP 0.47 g/g Cr U-B2MG 16,485 ng/ ml 6 ST U ABPC/TAZ 1.5 g/day 25 mm 54

18 K 1.5 meq/ L 10 15 201X 6 7 38 AKI 6,7 ACTH SS-A SS-B 15.1 ng/ml/h 177 pg/ ml PAC/PRA 12 ACTH 27.85 pg/ml 2 3.4 meq/l FEK 12.58 8,9 Mb CK AKI Mb 4 1 3 CK 10 ACC/AHA/NHLBI American College of Cardiology/American Heart Association/National Heart, Lung and Blood Institute 11 10 CK AKI CK CK 5,000 U/L AKI 12 Peak CK 15,000 20,000 U/L AKI 4 Peak CK 16,000 U/L 58 11 13 RRT prediction score 14 AKI

19 2 RRT 17.8 kda β2-microglobin 11.8 kda high-flux 0.8 super high flux 15 NF- 1.6H 2 FB-110U AKI RRT 16 AKI RRT 2 1 Liaño F, Pascual J: Epidemiology of acute renal failure: a prospective, multicenter, communitybased study. Madrid Acute Renal Failure Study Group. Kidney Int, 50(3): 811 818, 1996. 2 Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, et al.: Program to Improve Care in Acute Renal Disease: Spectrum of acute renal failure in the intensive care unit:the PICARD experience. Kidney Int, 66(4): 1613 1621, 2004. 3 76(4): 617 622, 2014.

20 4 Bosch X, Poch E, Grau JM: Rhabdomyolysis and acute kidney injury. N Engl J Med, 361: 62 72, 2009. 5 Zimmerman JL, Shen MC: Rhabdomyolysis. CHEST, 144(3): 1058 1065, 2013. 6 243 246, 2001. 7 Knochel JP, Schilen EM: On the mechanism of rhabdomyolysis in potassium depletion. J Clin Invest, 51: 1750 1758, 1972. 8 Merante A, Gareri P, Marigliano NM, De Fazio S, Bonacci E, Torchia C, et al.: Laxative-induced rhabdomyolysis. Clin Interv Aging, 5: 71 73, 2010. 9 Saglam O, Filik L: A case of sodium picosulphateinduced rhabdomyolysis. Acta Clin Belg, 70(4): 307, 2015. 10 Giannoglou GD, Chatzizisis YS, Misirli G: The syndrome of Rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med, 18: 90 100, 2007. 11 Pasternak RC, Smith SC, Jr. Bairey-Merz CN, et al.: ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Circuration, 106: 1024 1028, 2002. 12 Brown CV, Rhee P, Chan L, et al.: Preventing renal failure in patient rhabdomyolysis: do bicarbonate and mannitol make adifference? J Tauma, 56: 1191 1196, 2004. 13 Ward MM: Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med, 148: 1553 1557, 1988. 14 McMahon GM, Zeng X, Waikar SS: A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med, 173(19): 1821 1828, 2013. 15 Naka T, et al.: Myoglobin clearance by super highflux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care, 9: R90 95, 2005. 16 Petejova N, Martinek A: Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care, 18(3): 224, 2014.